Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Bateman

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Pediatric Pulmonology|October 22, 2010
Global strategy for the diagnosis and management of asthma in children 5 years and youngerSoren Erik Pedersen, Suzanne S Hurd, Robert F Lemanske, et al.
The European Respiratory Journal|June 30, 2012
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease studyAnamika Jithoo, Paul L Enright, Peter Burney, et al.
The New England Journal of Medicine|May 17, 2018
Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 16, 2012
Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroidsEugene R Bleecker, Eric D Bateman, William W Busse, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|August 15, 2008
Development of a South African integrated syndromic respiratory disease guideline for primary careRené G English, Eric D Bateman, Merrick F Zwarenstein, et al.
Respiratory Medicine|December 4, 2013
Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trialJan Lötvall, Eugene R Bleecker, William W Busse, et al.
Respiratory Medicine|January 29, 2022
Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma"Eric D Bateman, Asif H Khan, Yingxin Xu, et al.
Annals of the American Thoracic Society|May 12, 2021
Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2Eric D Bateman, Paul M O'Byrne, J Mark FitzGerald, et al.
Respiratory Medicine|August 26, 2020
Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)Eric D Bateman, Asif H Khan, Yingxin Xu, et al.
The New England Journal of Medicine|May 17, 2018
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild AsthmaEric D Bateman, Helen K Reddel, Paul M O'Byrne, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Pediatric Pulmonology|October 22, 2010
Global strategy for the diagnosis and management of asthma in children 5 years and youngerSoren Erik Pedersen, Suzanne S Hurd, Robert F Lemanske, et al.
The European Respiratory Journal|June 30, 2012
Case-finding options for COPD: results from the Burden of Obstructive Lung Disease studyAnamika Jithoo, Paul L Enright, Peter Burney, et al.
The New England Journal of Medicine|May 17, 2018
Inhaled Combined Budesonide-Formoterol as Needed in Mild AsthmaPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 16, 2012
Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroidsEugene R Bleecker, Eric D Bateman, William W Busse, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|August 15, 2008
Development of a South African integrated syndromic respiratory disease guideline for primary careRené G English, Eric D Bateman, Merrick F Zwarenstein, et al.
Respiratory Medicine|December 4, 2013
Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trialJan Lötvall, Eugene R Bleecker, William W Busse, et al.
Respiratory Medicine|January 29, 2022
Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma"Eric D Bateman, Asif H Khan, Yingxin Xu, et al.
Annals of the American Thoracic Society|May 12, 2021
Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2Eric D Bateman, Paul M O'Byrne, J Mark FitzGerald, et al.
Respiratory Medicine|August 26, 2020
Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)Eric D Bateman, Asif H Khan, Yingxin Xu, et al.
The New England Journal of Medicine|May 17, 2018
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild AsthmaEric D Bateman, Helen K Reddel, Paul M O'Byrne, et al.
Pageof 17